3,250 VND
72.19 B VND
948.12 B VND
About VIDIPHA CENTRAL PHARMACEUTICAL JOINT - STOCK COMPANY
Sector
Industry
CEO
Hoa Van Hoang
Website
Headquarters
Ho Chi Minh City
Founded
1976
ISIN
VN000000VDP2
FIGI
BBG00H5S8Y48
Vidipha Central Pharmaceutical JSC engages in the manufacture, import, export and trade of pharmaceuticals. It offers antibiotics, antispasmodics, antiemetic, respiratory, cardiovascular, antiseptics, diabetes drugs, digestive, antifungal, worm treatment, distilled water, vitamins and minerals. The company was founded on November 24, 1976 and is headquartered in Ho Chi Minh City, Vietnam.
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of VDP is 36,000 VND — it has decreased by −1.37% in the past 24 hours. Watch VIDIPHA CENTRAL PHARMACEUTICAL JOINT - STOCK COMPANY stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HOSE exchange VIDIPHA CENTRAL PHARMACEUTICAL JOINT - STOCK COMPANY stocks are traded under the ticker VDP.
VDP stock has fallen by −0.14% compared to the previous week, the month change is a 9.09% rise, over the last year VIDIPHA CENTRAL PHARMACEUTICAL JOINT - STOCK COMPANY has showed a 13.39% increase.
VDP stock is 0.00% volatile and has beta coefficient of 0.13. Track VIDIPHA CENTRAL PHARMACEUTICAL JOINT - STOCK COMPANY stock price on the chart and check out the list of the most volatile stocks — is VIDIPHA CENTRAL PHARMACEUTICAL JOINT - STOCK COMPANY there?
Today VIDIPHA CENTRAL PHARMACEUTICAL JOINT - STOCK COMPANY has the market capitalization of 795.00 B, it has increased by 7.99% over the last week.
Yes, you can track VIDIPHA CENTRAL PHARMACEUTICAL JOINT - STOCK COMPANY financials in yearly and quarterly reports right on TradingView.
VDP net income for the last quarter is 23.44 B VND, while the quarter before that showed 15.57 B VND of net income which accounts for 50.58% change. Track more VIDIPHA CENTRAL PHARMACEUTICAL JOINT - STOCK COMPANY financial stats to get the full picture.
VIDIPHA CENTRAL PHARMACEUTICAL JOINT - STOCK COMPANY dividend yield was 6.76% in 2024, and payout ratio reached 76.47%. The year before the numbers were 6.41% and 52.46% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. VIDIPHA CENTRAL PHARMACEUTICAL JOINT - STOCK COMPANY EBITDA is 113.58 B VND, and current EBITDA margin is 11.98%. See more stats in VIDIPHA CENTRAL PHARMACEUTICAL JOINT - STOCK COMPANY financial statements.
Like other stocks, VDP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VIDIPHA CENTRAL PHARMACEUTICAL JOINT - STOCK COMPANY stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So VIDIPHA CENTRAL PHARMACEUTICAL JOINT - STOCK COMPANY technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating VIDIPHA CENTRAL PHARMACEUTICAL JOINT - STOCK COMPANY stock shows the buy signal. See more of VIDIPHA CENTRAL PHARMACEUTICAL JOINT - STOCK COMPANY technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.